Abner Herrman & Brock LLC Raises Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Abner Herrman & Brock LLC boosted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 127,878 shares of the company’s stock after buying an additional 1,026 shares during the quarter. Abner Herrman & Brock LLC’s holdings in GE HealthCare Technologies were worth $9,997,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the stock. LGT Financial Advisors LLC boosted its position in GE HealthCare Technologies by 1,673.3% during the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after purchasing an additional 251 shares in the last quarter. Ashton Thomas Securities LLC purchased a new stake in shares of GE HealthCare Technologies during the third quarter valued at about $26,000. Capital Performance Advisors LLP purchased a new position in shares of GE HealthCare Technologies in the 3rd quarter worth approximately $26,000. Darwin Wealth Management LLC purchased a new stake in GE HealthCare Technologies during the third quarter valued at approximately $31,000. Finally, Continuum Advisory LLC lifted its holdings in shares of GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after purchasing an additional 168 shares during the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

GEHC has been the subject of a number of research analyst reports. Wells Fargo & Company raised their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research note on Thursday, October 31st. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price objective for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $96.00.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $88.30 on Monday. The firm’s 50-day moving average is $82.87 and its two-hundred day moving average is $85.04. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The stock has a market capitalization of $40.34 billion, a P/E ratio of 24.26, a P/E/G ratio of 2.92 and a beta of 1.14. GE HealthCare Technologies Inc. has a 12-month low of $72.52 and a 12-month high of $94.55.

GE HealthCare Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be issued a $0.035 dividend. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date is Tuesday, January 14th. This represents a $0.14 annualized dividend and a yield of 0.16%. GE HealthCare Technologies’s payout ratio is 3.85%.

Insider Transactions at GE HealthCare Technologies

In related news, CEO Roland Rott sold 3,577 shares of the business’s stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the transaction, the chief executive officer now owns 24,298 shares in the company, valued at approximately $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.27% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.